TWO SIGMA INVESTMENTS, LP
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 1179392
NEW YORK, NY
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$924,097
-$233,294 QoQ
Shares Held
69,481
-44.1% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 158 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,272,047,596 across 342 Biotechnology names. FDMT ranks #209 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in FDMT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $924,097 | 69,481 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,157,391 | 124,317 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,531,272 | 337,503 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,376,680 | 273,496 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,970,614 | 531,163 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,490,506 | 461,457 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,748,941 | 313,993 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,145,557 | 105,972 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $577,707 | 27,523 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,000,435 | 31,401 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $1,296,715 | 101,863 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,345,461 | 185,139 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,453,178 | 200,883 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,419,762 | 153,974 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $132,249 | 16,449 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $321,045 | 45,995 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $237,384 | 15,700 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,554,383 | 70,847 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||